Cutispharma Holdings
Raleigh, US · Founded 2018 · Delaware corporation
Founders & leadership
DR
DAVE RITCHIENamed on SEC filing
NM
NEAL MUNINamed on SEC filing
FL
FRANK LEONamed on SEC filing
GP
GAETANO PETRELLINamed on SEC filing
AP
AMIT PATELNamed on SEC filing
JE
JEFF EDWARDSNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$69.9M disclosed across 1 round · 2018
▶$69.9MraisedApr 2018 · 16 investors · PharmaceuticalsRule 506(b)
▶$69.9MraisedApr 2018 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- DAVE RITCHIEDirector
- NEAL MUNIExecutive Officer, Director
- FRANK LEODirector
- GAETANO PETRELLIExecutive Officer, Director
- AMIT PATELDirector
- JEFF EDWARDSExecutive Officer, Director
- Offering amount
- $69.9M
- Amount sold
- $69.9M
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cutispharma Holdings raised?
- Cutispharma Holdings has disclosed $69.9M raised across 1 round.
- Where is Cutispharma Holdings headquartered?
- Cutispharma Holdings is headquartered in Raleigh, US.